Αρχειοθήκη ιστολογίου

Δευτέρα 12 Ιουνίου 2017

CAR T Cell/Ibrutinib Combination May Improve CLL Response Rates

Despite immune-related adverse events, concurrent ibrutinib and anti-CD19 CAR T-cell therapy may improve response rates in patients with chronic lymphocytic leukemia. (Source: CancerNetwork)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2sSTDSV
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader